Concepedia
Statistics
Publications
15
Citations
1.2K
H-Index
13
Active since
1987
Affiliations
University of Cambridge(Current)
MSD (UK) Limited (United Kingdom)
Dalhousie University
Huntercombe Hospital
Berkshire College of Agriculture
Kelly J. Stanhope is an author at University of Cambridge specializing in neuropharmacology, pharmacology, and neuroscience.
Publications per year
1987–2005
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
Allan Fletcher, Elaine A. Forster, David J. Bill et al. · Behavioural Brain Research · 1995 · 521 citations
Medicine, Neuroscience, Pharmacology +13
The Muscarinic Receptor Agonist Xanomeline Has an Antipsychotic-Like Profile in the Rat
Kelly J. Stanhope, Nawazish Mirza, Mike Bickerdike et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 129 citations
Medicine, Neuroscience, Pharmacology +15
One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure
Gerard R. Dawson, Susan P. Crawford, Kelly J. Stanhope et al. · Psychopharmacology · 1994 · 96 citations
Medicine, Neuroscience, Pharmacology +6
Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists
Kelly J. Stanhope, A. P. McLenachan, Colin T. Dourish · Psychopharmacology · 1995 · 87 citations
Life Sciences, Behavioral Sciences, Neuroscience +14
The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys
Amy F.T. Arnsten, Chaoshuang Lin, Christopher H. van Dyck et al. · Neurobiology of Aging · 1997 · 67 citations · Full text
Medicine, Neuroscience, Pharmacology +14
1–5 of 15